康萃 蜂王乳+芝麻錠
康萃 蜂王乳+芝麻錠 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| ROYAL JELLY | ROYAL JELLY | Gelée royale |
| WHITE SESAME EXTRACT | WHITE SESAME EXTRACT | Not identified |
| VITAMIN E (D-ALPHA TOCOPHEROL) | VITAMIN E (D-ALPHA TOCOPHEROL) | Vitamine E |
| STARCH SODIUM OCTENYL SUCCINATE | STARCH SODIUM OCTENYL SUCCINATE | Not identified |
| MICROCRYSTALLINE α-CELLULOSE | MICROCRYSTALLINE α-CELLULOSE | Not identified |
| SILICON DIOXIDE | SILICON DIOXIDE | Not identified |
| VITAMIN C (ASCORBIC ACID) | VITAMIN C (ASCORBIC ACID) | Vitamine C |
| SWALLOW NEST EXTRACT | SWALLOW NEST EXTRACT | Not identified |
| DEXTRIN | DEXTRIN | Not identified |
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE | Not identified |
| CALCIUM STEARATE | CALCIUM STEARATE | Not identified |
| GUAR GUM | GUAR GUM | Not identified |
| SHELLAC | SHELLAC | Not identified |
| SODIUM ACETATE | SODIUM ACETATE | Not identified |
| PALM OIL | PALM OIL | Not identified |
| GLYCERIN FATTY ACID ESTER | GLYCERIN FATTY ACID ESTER | Not identified |
| HYDROXYPROPYL METHYLCELLULOSE | HYDROXYPROPYL METHYLCELLULOSE | Not identified |
| GLYCEROL | GLYCEROL | Glycérol |
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | Not identified |
| TARTRAZINE | TARTRAZINE | Not identified |
| CARNAUBA WAX | CARNAUBA WAX | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- 1100027794
- Chinese name
- 康萃 蜂王乳+芝麻錠
- English name
- BEE ZIN ROYAL JELLY + SESAME TABLET
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 永茂生技實業股份有限公司
- Registration date
- 2021-10-08
- Published validity end
- 2026-10-08
Original register data
View published fields and their variants
- Product name
- 康萃 蜂王乳+芝麻錠
- Active ingredients
- ROYAL JELLY;;WHITE SESAME EXTRACT;;VITAMIN E (D-ALPHA TOCOPHEROL);;STARCH SODIUM OCTENYL SUCCINATE;;MICROCRYSTALLINE α-CELLULOSE;;SILICON DIOXIDE;;VITAMIN C (ASCORBIC ACID);;SWALLOW NEST EXTRACT;;DEXTRIN;;MICROCRYSTALLINE α-CELLULOSE;;HYDROXYPROPYL CELLULOSE;;SILICON DIOXIDE;;CALCIUM STEARATE;;GUAR GUM;;SHELLAC;;HYDROXYPROPYL CELLULOSE;;SODIUM ACETATE;;PALM OIL;;GLYCERIN FATTY ACID ESTER;;HYDROXYPROPYL METHYLCELLULOSE;;GLYCEROL;;TITANIUM DIOXIDE;;TARTRAZINE;;CARNAUBA WAX;;
- Valid until
- 1151008
- Registration number
- 1100027794
- Licence holder
- 永茂生技實業股份有限公司
- Registration date
- 1101008
- Published reference
- DHC0B000277947
- Published English name
- BEE ZIN ROYAL JELLY + SESAME TABLET
Official source
View the official register, number 1100027794
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- ROYAL JELLY
Read the warning, when it applies and the studies cited
ROYAL JELLY
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Contraindications
Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).
Sources cited by Health Canada (8)
- Bullock RJ. Fatal royal-jelly induced asthma. Medical Journal of Australia 1994;160:44. PubMed Case report
- Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report
- Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
- Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
- Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
- Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
- TGA 2001: Australian Therapeutic Goods Administration. CMEC 28: Complementary Medicines Evaluation Committee, Extracted Ratified Minutes twenty-eight Meeting, 27-28 July 2001. Australian Government Department of Health and Aging, Sydney, Australia; 2001. [Accessed 2025 February 5]. Available from: https://www.tga.gov.au/sites/default/files/cmec-minutes-28.pdf
- Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).
Sources cited by Health Canada (6)
- Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
- Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
- Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
- Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
- Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
- Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “康萃 蜂王乳+芝麻錠”, https://compoatlas.com/en/supplements/taiwan/1100027794-bee-zin-royal-jelly-sesame-tablet, updated 27 October 2026.